Lifileucel for the treatment of adult patients with unresectable or metastatic melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor with or without a MEK inhibitor.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/zVSGZmt
No comments:
Post a Comment